EDGAR Filing Documents for 0001179110-04-002425

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001179110-04-002425

Filing Date

2004-02-04

Accepted

2004-02-04 16:24:40

Documents

Period of Report

2004-01-28

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 -	edgar.html	4
1	FORM 4 -	edgar.xml	4	13025
	Complete submission text file	0001179110-04-002425.txt		15134

Mailing Address 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019

Business Address 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019 2125544555

MANHATTAN PHARMACEUTICALS INC (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 350 FIFTH AVENUE SUITE 5507 NEW YORK NY 10118

Business Address 350 FIFTH AVENUE SUITE 5507 NEW YORK NY 10118 2122672503X203

Type: 4 | Act: 34 | File No.: 000-27282 | Film No.: 04567132